APO Research
Talk to an analyst

APO RESEARCH · REPORT

One-Stop Service for Gene-Edited Cell Lines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global One-Stop Service for Gene-Edited Cell Lines Market Outlook and Growth Opportunities 2026

15 April 2026Not stated

Choose your research edition.

Industry ResearchOne-Stop Service for Gene-Edited Cell Lines Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal One-Stop Service for Gene-Edited Cell Lines Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal One-Stop Service for Gene-Edited Cell Lines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal One-Stop Service for Gene-Edited Cell Lines Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal One-Stop Service for Gene-Edited Cell Lines Market Analysis and Forecast 2026-2032183 pages · $4,950 USD

Market perspective

The global One-Stop Service for Gene-Edited Cell Lines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for One-Stop Service for Gene-Edited Cell Lines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for One-Stop Service for Gene-Edited Cell Lines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for One-Stop Service for Gene-Edited Cell Lines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the One-Stop Service for Gene-Edited Cell Lines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the One-Stop Service for Gene-Edited Cell Lines market include Amsbio, Charles River Laboratories, Creative Biogene, Cytiva, Eurofins Genomics, Evotec, GenScript, Horizon Discovery and Lonza, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global One-Stop Service for Gene-Edited Cell Lines market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of One-Stop Service for Gene-Edited Cell Lines and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents One-Stop Service for Gene-Edited Cell Lines revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global One-Stop Service for Gene-Edited Cell Lines market.

One-Stop Service for Gene-Edited Cell Lines Segment by Company

Amsbio

Charles River Laboratories

Creative Biogene

Cytiva

Eurofins Genomics

Evotec

GenScript

Horizon Discovery

Lonza

ViroCell Biologics

Sartorius

Synbio Technologies

Takara Bio

Thermo Fisher Scientific

BoyaLife

HEMABIO

BGI Genomics

GenScript Biotech

Shanghai Model Organisms

Vazyme

One-Stop Service for Gene-Edited Cell Lines Segment by Type

Gene Knockout Service

Gene Knockin Service

One-Stop Service for Gene-Edited Cell Lines Segment by Application

Universities and Research Institutions

Biopharmaceutical Industry

Others

One-Stop Service for Gene-Edited Cell Lines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global One-Stop Service for Gene-Edited Cell Lines status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the One-Stop Service for Gene-Edited Cell Lines key companies, revenue, market share, and recent developments.

3. To split the One-Stop Service for Gene-Edited Cell Lines breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions One-Stop Service for Gene-Edited Cell Lines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify One-Stop Service for Gene-Edited Cell Lines significant trends, drivers, influence factors in global and regions.

6. To analyze One-Stop Service for Gene-Edited Cell Lines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global One-Stop Service for Gene-Edited Cell Lines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of One-Stop Service for Gene-Edited Cell Lines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of One-Stop Service for Gene-Edited Cell Lines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global One-Stop Service for Gene-Edited Cell Lines industry.

Chapter 3: Detailed analysis of One-Stop Service for Gene-Edited Cell Lines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of One-Stop Service for Gene-Edited Cell Lines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of One-Stop Service for Gene-Edited Cell Lines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. One-Stop Service for Gene-Edited Cell Lines Industry Trends Table 2. One-Stop Service for Gene-Edited Cell Lines Industry Drivers Table 3. One-Stop Service for Gene-Edited Cell Lines Industry Opportunities and Challenges Table 4. One-Stop Service for Gene-Edited Cell Lines Industry Restraints Table 5. Global One-Stop Service for Gene-Edited Cell Lines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global One-Stop Service for Gene-Edited Cell Lines Revenue Share by Company (2021-2026) Table 7. Global One-Stop Service for Gene-Edited Cell Lines Company Ranking, (2024-2026) & (US$ Million) Table 8. Global One-Stop Service for Gene-Edited Cell Lines Key Company Manufacturing Base & Headquarters Table 9. Global One-Stop Service for Gene-Edited Cell Lines Company, Product Type & Application Table 10. Global One-Stop Service for Gene-Edited Cell Lines Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global One-Stop Service for Gene-Edited Cell Lines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Gene Knockout Service Table 15. Significant Companies of Gene Knockin Service Table 16. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type (2021-2026) Table 20. Global One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Universities and Research Institutions Table 22. Significant Companies of Biopharmaceutical Industry Table 23. Significant Companies of Others Table 24. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application (2021-2026) Table 28. Global One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application (2027-2032) Table 29. Global One-Stop Service for Gene-Edited Cell Lines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Region (2021-2026) Table 32. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Region (2027-2032) Table 34. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global One-Stop Service for Gene-Edited Cell Lines Sales Value Market Share by Country (2021-2026) Table 37. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global One-Stop Service for Gene-Edited Cell Lines Sales Value Market Share by Country (2027-2032) Table 39. Amsbio Company Information Table 40. Amsbio Business Overview Table 41. Amsbio One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Amsbio One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 43. Amsbio Recent Development Table 44. Charles River Laboratories Company Information Table 45. Charles River Laboratories Business Overview Table 46. Charles River Laboratories One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Charles River Laboratories One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 48. Charles River Laboratories Recent Development Table 49. Creative Biogene Company Information Table 50. Creative Biogene Business Overview Table 51. Creative Biogene One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Creative Biogene One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 53. Creative Biogene Recent Development Table 54. Cytiva Company Information Table 55. Cytiva Business Overview Table 56. Cytiva One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Cytiva One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 58. Cytiva Recent Development Table 59. Eurofins Genomics Company Information Table 60. Eurofins Genomics Business Overview Table 61. Eurofins Genomics One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Eurofins Genomics One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 63. Eurofins Genomics Recent Development Table 64. Evotec Company Information Table 65. Evotec Business Overview Table 66. Evotec One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Evotec One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 68. Evotec Recent Development Table 69. GenScript Company Information Table 70. GenScript Business Overview Table 71. GenScript One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. GenScript One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 73. GenScript Recent Development Table 74. Horizon Discovery Company Information Table 75. Horizon Discovery Business Overview Table 76. Horizon Discovery One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Horizon Discovery One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 78. Horizon Discovery Recent Development Table 79. Lonza Company Information Table 80. Lonza Business Overview Table 81. Lonza One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Lonza One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 83. Lonza Recent Development Table 84. ViroCell Biologics Company Information Table 85. ViroCell Biologics Business Overview Table 86. ViroCell Biologics One-Stop Service for Gene-Edited Cell Lines Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. ViroCell Biologics One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 88. ViroCell Biologics Recent Development Table 89. Sartorius Company Information Table 90. Sartorius Business Overview Table 91. Sartorius One-Stop Service for Gene-Edited Cell Lines Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Sartorius One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 93. Sartorius Recent Development Table 94. Synbio Technologies Company Information Table 95. Synbio Technologies Business Overview Table 96. Synbio Technologies One-Stop Service for Gene-Edited Cell Lines Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Synbio Technologies One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 98. Synbio Technologies Recent Development Table 99. Takara Bio Company Information Table 100. Takara Bio Business Overview Table 101. Takara Bio One-Stop Service for Gene-Edited Cell Lines Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Takara Bio One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 103. Takara Bio Recent Development Table 104. Thermo Fisher Scientific Company Information Table 105. Thermo Fisher Scientific Business Overview Table 106. Thermo Fisher Scientific One-Stop Service for Gene-Edited Cell Lines Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Thermo Fisher Scientific One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 108. Thermo Fisher Scientific Recent Development Table 109. BoyaLife Company Information Table 110. BoyaLife Business Overview Table 111. BoyaLife One-Stop Service for Gene-Edited Cell Lines Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. BoyaLife One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 113. BoyaLife Recent Development Table 114. HEMABIO Company Information Table 115. HEMABIO Business Overview Table 116. HEMABIO One-Stop Service for Gene-Edited Cell Lines Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. HEMABIO One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 118. HEMABIO Recent Development Table 119. BGI Genomics Company Information Table 120. BGI Genomics Business Overview Table 121. BGI Genomics One-Stop Service for Gene-Edited Cell Lines Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. BGI Genomics One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 123. BGI Genomics Recent Development Table 124. GenScript Biotech Company Information Table 125. GenScript Biotech Business Overview Table 126. GenScript Biotech One-Stop Service for Gene-Edited Cell Lines Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. GenScript Biotech One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 128. GenScript Biotech Recent Development Table 129. Shanghai Model Organisms Company Information Table 130. Shanghai Model Organisms Business Overview Table 131. Shanghai Model Organisms One-Stop Service for Gene-Edited Cell Lines Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. Shanghai Model Organisms One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 133. Shanghai Model Organisms Recent Development Table 134. Vazyme Company Information Table 135. Vazyme Business Overview Table 136. Vazyme One-Stop Service for Gene-Edited Cell Lines Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Vazyme One-Stop Service for Gene-Edited Cell Lines Product Portfolio Table 138. Vazyme Recent Development Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. One-Stop Service for Gene-Edited Cell Lines Product Image Figure 2. Global One-Stop Service for Gene-Edited Cell Lines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global One-Stop Service for Gene-Edited Cell Lines Market Size (2021-2032) & (US$ Million) Figure 4. Global One-Stop Service for Gene-Edited Cell Lines Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Gene Knockout Service Image Figure 8. Gene Knockin Service Image Figure 9. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global One-Stop Service for Gene-Edited Cell Lines Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type (2021-2032) Figure 12. Universities and Research Institutions Image Figure 13. Biopharmaceutical Industry Image Figure 14. Others Image Figure 15. Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global One-Stop Service for Gene-Edited Cell Lines Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application (2021-2032) Figure 18. Global One-Stop Service for Gene-Edited Cell Lines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America One-Stop Service for Gene-Edited Cell Lines Sales Value (2021-2032) & (US$ Million) Figure 21. North America One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe One-Stop Service for Gene-Edited Cell Lines Sales Value (2021-2032) & (US$ Million) Figure 23. Europe One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific One-Stop Service for Gene-Edited Cell Lines Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America One-Stop Service for Gene-Edited Cell Lines Sales Value (2021-2032) & (US$ Million) Figure 27. South America One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa One-Stop Service for Gene-Edited Cell Lines Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Gene Knockout Service
  • Gene Knockin Service
Applications
  • Universities and Research Institutions
  • Biopharmaceutical Industry
  • Others
Companies covered
  • Amsbio
  • Charles River Laboratories
  • Creative Biogene
  • Cytiva
  • Eurofins Genomics
  • Evotec
  • GenScript
  • Horizon Discovery
  • Lonza
  • ViroCell Biologics
  • Sartorius
  • Synbio Technologies
  • Takara Bio
  • Thermo Fisher Scientific
  • BoyaLife
  • HEMABIO
  • BGI Genomics
  • GenScript Biotech
  • Shanghai Model Organisms
  • Vazyme

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global One-Stop Service for Gene-Edited Cell Lines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global One-Stop Service for Gene-Edited Cell Lines Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 One-Stop Service for Gene-Edited Cell Lines Market Dynamics
  1. 2.1 One-Stop Service for Gene-Edited Cell Lines Industry Trends
  2. 2.2 One-Stop Service for Gene-Edited Cell Lines Industry Drivers
  3. 2.3 One-Stop Service for Gene-Edited Cell Lines Industry Opportunities and Challenges
  4. 2.4 One-Stop Service for Gene-Edited Cell Lines Industry Restraints
3 One-Stop Service for Gene-Edited Cell Lines Market by Company
  1. 3.1 Global One-Stop Service for Gene-Edited Cell Lines Company Revenue Ranking in 2025
  2. 3.2 Global One-Stop Service for Gene-Edited Cell Lines Revenue by Company (2021-2026)
  3. 3.3 Global One-Stop Service for Gene-Edited Cell Lines Company Ranking (2024-2026)
  4. 3.4 Global One-Stop Service for Gene-Edited Cell Lines Company Manufacturing Base and Headquarters
  5. 3.5 Global One-Stop Service for Gene-Edited Cell Lines Company Product Type and Application
  6. 3.6 Global One-Stop Service for Gene-Edited Cell Lines Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global One-Stop Service for Gene-Edited Cell Lines Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 One-Stop Service for Gene-Edited Cell Lines Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 One-Stop Service for Gene-Edited Cell Lines Market by Type
  1. 4.1 One-Stop Service for Gene-Edited Cell Lines Type Introduction
  2. 4.1.1 Gene Knockout Service
  3. 4.1.2 Gene Knockin Service
  4. 4.2 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Type
  5. 4.2.1 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Type (2021-2032)
  7. 4.2.3 Global One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type (2021-2032)
5 One-Stop Service for Gene-Edited Cell Lines Market by Application
  1. 5.1 One-Stop Service for Gene-Edited Cell Lines Application Introduction
  2. 5.1.1 Universities and Research Institutions
  3. 5.1.2 Biopharmaceutical Industry
  4. 5.1.3 Others
  5. 5.2 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Application
  6. 5.2.1 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Application (2021-2032)
  8. 5.2.3 Global One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application (2021-2032)
6 One-Stop Service for Gene-Edited Cell Lines Regional Value Analysis
  1. 6.1 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Region (2021-2032)
  3. 6.2.1 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Region: 2021-2026
  4. 6.2.2 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America One-Stop Service for Gene-Edited Cell Lines Sales Value (2021-2032)
  7. 6.3.2 North America One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe One-Stop Service for Gene-Edited Cell Lines Sales Value (2021-2032)
  10. 6.4.2 Europe One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific One-Stop Service for Gene-Edited Cell Lines Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America One-Stop Service for Gene-Edited Cell Lines Sales Value (2021-2032)
  16. 6.6.2 South America One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa One-Stop Service for Gene-Edited Cell Lines Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Country, 2025 VS 2032
7 One-Stop Service for Gene-Edited Cell Lines Country-level Value Analysis
  1. 7.1 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Country (2021-2032)
  3. 7.2.1 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Country (2021-2026)
  4. 7.2.2 Global One-Stop Service for Gene-Edited Cell Lines Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt One-Stop Service for Gene-Edited Cell Lines Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt One-Stop Service for Gene-Edited Cell Lines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Amsbio
  2. 8.1.1 Amsbio Company Information
  3. 8.1.2 Amsbio Business Overview
  4. 8.1.3 Amsbio One-Stop Service for Gene-Edited Cell Lines Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Amsbio One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  6. 8.1.5 Amsbio Recent Developments
  7. 8.2 Charles River Laboratories
  8. 8.2.1 Charles River Laboratories Company Information
  9. 8.2.2 Charles River Laboratories Business Overview
  10. 8.2.3 Charles River Laboratories One-Stop Service for Gene-Edited Cell Lines Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Charles River Laboratories One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  12. 8.2.5 Charles River Laboratories Recent Developments
  13. 8.3 Creative Biogene
  14. 8.3.1 Creative Biogene Company Information
  15. 8.3.2 Creative Biogene Business Overview
  16. 8.3.3 Creative Biogene One-Stop Service for Gene-Edited Cell Lines Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Creative Biogene One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  18. 8.3.5 Creative Biogene Recent Developments
  19. 8.4 Cytiva
  20. 8.4.1 Cytiva Company Information
  21. 8.4.2 Cytiva Business Overview
  22. 8.4.3 Cytiva One-Stop Service for Gene-Edited Cell Lines Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Cytiva One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  24. 8.4.5 Cytiva Recent Developments
  25. 8.5 Eurofins Genomics
  26. 8.5.1 Eurofins Genomics Company Information
  27. 8.5.2 Eurofins Genomics Business Overview
  28. 8.5.3 Eurofins Genomics One-Stop Service for Gene-Edited Cell Lines Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Eurofins Genomics One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  30. 8.5.5 Eurofins Genomics Recent Developments
  31. 8.6 Evotec
  32. 8.6.1 Evotec Company Information
  33. 8.6.2 Evotec Business Overview
  34. 8.6.3 Evotec One-Stop Service for Gene-Edited Cell Lines Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Evotec One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  36. 8.6.5 Evotec Recent Developments
  37. 8.7 GenScript
  38. 8.7.1 GenScript Company Information
  39. 8.7.2 GenScript Business Overview
  40. 8.7.3 GenScript One-Stop Service for Gene-Edited Cell Lines Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GenScript One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  42. 8.7.5 GenScript Recent Developments
  43. 8.8 Horizon Discovery
  44. 8.8.1 Horizon Discovery Company Information
  45. 8.8.2 Horizon Discovery Business Overview
  46. 8.8.3 Horizon Discovery One-Stop Service for Gene-Edited Cell Lines Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Horizon Discovery One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  48. 8.8.5 Horizon Discovery Recent Developments
  49. 8.9 Lonza
  50. 8.9.1 Lonza Company Information
  51. 8.9.2 Lonza Business Overview
  52. 8.9.3 Lonza One-Stop Service for Gene-Edited Cell Lines Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lonza One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  54. 8.9.5 Lonza Recent Developments
  55. 8.10 ViroCell Biologics
  56. 8.10.1 ViroCell Biologics Company Information
  57. 8.10.2 ViroCell Biologics Business Overview
  58. 8.10.3 ViroCell Biologics One-Stop Service for Gene-Edited Cell Lines Revenue and Gross Margin (2021-2026)
  59. 8.10.4 ViroCell Biologics One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  60. 8.10.5 ViroCell Biologics Recent Developments
  61. 8.11 Sartorius
  62. 8.11.1 Sartorius Company Information
  63. 8.11.2 Sartorius Business Overview
  64. 8.11.3 Sartorius One-Stop Service for Gene-Edited Cell Lines Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sartorius One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  66. 8.11.5 Sartorius Recent Developments
  67. 8.12 Synbio Technologies
  68. 8.12.1 Synbio Technologies Company Information
  69. 8.12.2 Synbio Technologies Business Overview
  70. 8.12.3 Synbio Technologies One-Stop Service for Gene-Edited Cell Lines Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Synbio Technologies One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  72. 8.12.5 Synbio Technologies Recent Developments
  73. 8.13 Takara Bio
  74. 8.13.1 Takara Bio Company Information
  75. 8.13.2 Takara Bio Business Overview
  76. 8.13.3 Takara Bio One-Stop Service for Gene-Edited Cell Lines Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Takara Bio One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  78. 8.13.5 Takara Bio Recent Developments
  79. 8.14 Thermo Fisher Scientific
  80. 8.14.1 Thermo Fisher Scientific Company Information
  81. 8.14.2 Thermo Fisher Scientific Business Overview
  82. 8.14.3 Thermo Fisher Scientific One-Stop Service for Gene-Edited Cell Lines Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Thermo Fisher Scientific One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  84. 8.14.5 Thermo Fisher Scientific Recent Developments
  85. 8.15 BoyaLife
  86. 8.15.1 BoyaLife Company Information
  87. 8.15.2 BoyaLife Business Overview
  88. 8.15.3 BoyaLife One-Stop Service for Gene-Edited Cell Lines Revenue and Gross Margin (2021-2026)
  89. 8.15.4 BoyaLife One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  90. 8.15.5 BoyaLife Recent Developments
  91. 8.16 HEMABIO
  92. 8.16.1 HEMABIO Company Information
  93. 8.16.2 HEMABIO Business Overview
  94. 8.16.3 HEMABIO One-Stop Service for Gene-Edited Cell Lines Revenue and Gross Margin (2021-2026)
  95. 8.16.4 HEMABIO One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  96. 8.16.5 HEMABIO Recent Developments
  97. 8.17 BGI Genomics
  98. 8.17.1 BGI Genomics Company Information
  99. 8.17.2 BGI Genomics Business Overview
  100. 8.17.3 BGI Genomics One-Stop Service for Gene-Edited Cell Lines Revenue and Gross Margin (2021-2026)
  101. 8.17.4 BGI Genomics One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  102. 8.17.5 BGI Genomics Recent Developments
  103. 8.18 GenScript Biotech
  104. 8.18.1 GenScript Biotech Company Information
  105. 8.18.2 GenScript Biotech Business Overview
  106. 8.18.3 GenScript Biotech One-Stop Service for Gene-Edited Cell Lines Revenue and Gross Margin (2021-2026)
  107. 8.18.4 GenScript Biotech One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  108. 8.18.5 GenScript Biotech Recent Developments
  109. 8.19 Shanghai Model Organisms
  110. 8.19.1 Shanghai Model Organisms Company Information
  111. 8.19.2 Shanghai Model Organisms Business Overview
  112. 8.19.3 Shanghai Model Organisms One-Stop Service for Gene-Edited Cell Lines Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Shanghai Model Organisms One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  114. 8.19.5 Shanghai Model Organisms Recent Developments
  115. 8.20 Vazyme
  116. 8.20.1 Vazyme Company Information
  117. 8.20.2 Vazyme Business Overview
  118. 8.20.3 Vazyme One-Stop Service for Gene-Edited Cell Lines Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Vazyme One-Stop Service for Gene-Edited Cell Lines Product Portfolio
  120. 8.20.5 Vazyme Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst